Next Article in Journal
Mutation in the pssA Gene Involved in Exopolysaccharide Synthesis Leads to Several Physiological and Symbiotic Defects in Rhizobium leguminosarum bv. trifolii
Next Article in Special Issue
CXCL10 Decreases GP73 Expression in Hepatoma Cells at the Early Stage of Hepatitis C Virus (HCV) Infection
Previous Article in Journal
Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
Previous Article in Special Issue
Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(12), 23700-23710;

Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein

Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Korea
Aging Regulation, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan
Author to whom correspondence should be addressed.
Received: 11 September 2013 / Revised: 21 November 2013 / Accepted: 21 November 2013 / Published: 4 December 2013
(This article belongs to the Collection Molecular Mechanisms of Human Liver Diseases)
Full-Text   |   PDF [1643 KB, uploaded 19 June 2014]


Smad3 is a key mediator of the transforming growth factor (TGF)-β1 signaling pathway that plays central role in inflammation and fibrosis. In present study, we evaluated the effect of Smad3 deficiency in Smad3−/− mice with carbon tetrachloride (CCl4)-induced liver fibrosis. The animals were received CCl4 or olive oil three times a week for 4 weeks. Histopathological analyses were performed to evaluate the fibrosis development in the mice. Alteration of protein expression controlled by Smad3 was examined using a proteomic analysis. CCl4-induced liver fibrosis was rarely detected in Smad3−/− mice compared to Smad3+/+. Proteomic analysis revealed that proteins related to antioxidant activities such as senescence marker protein-30 (SMP30), selenium-binding proteins (SP56) and glutathione S-transferases (GSTs) were up-regulated in Smad3−/− mice. Western blot analysis confirmed that SMP30 protein expression was increased in Smad3−/− mice. And SMP30 levels were decreased in CCl4-treated Smad3+/+ and Smad3−/− mice. These results indicate that Smad3 deficiency influences the proteins level related to antioxidant activities during early liver fibrosis. Thus, we suggest that Smad3 deteriorate hepatic injury by inhibitor of antioxidant proteins as well as mediator of TGF-β1 signaling. View Full-Text
Keywords: liver fibrosis; Smad3; SMP-30; antioxidant liver fibrosis; Smad3; SMP-30; antioxidant
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Jeong, D.-H.; Hwang, M.; Park, J.-K.; Goo, M.-J.; Hong, I.-H.; Ki, M.-R.; Ishigami, A.; Kim, A.-Y.; Lee, E.-M.; Lee, E.-J.; Jeong, K.-S. Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein. Int. J. Mol. Sci. 2013, 14, 23700-23710.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top